News: Valeant Pharmaceuticals International Inc (VRX.N)

VRX.N on New York Stock Exchange

140.33USD
24 Dec 2014
Price Change (% chg)

$-0.22 (-0.16%)
Prev Close
$140.55
Open
$140.50
Day's High
$142.15
Day's Low
$139.94
Volume
116,704
Avg. Vol
370,179
52-wk High
$152.92
52-wk Low
$106.03

Search Stocks
Select another date:

Tue, Dec 9 2014

Photo

Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

NEW YORK/WINNIPEG - Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a stronger position, people familiar with the matter told Reuters.

UPDATE 1-Market Chatter-Corporate finance press digest

Dec 9 - The following corporate finance-related stories were reported by media:

A

CORRECTED-BRIEF-Valeant Pharma reports 0.1 percent stake in Allergan

(Corrects first bullet point to remove incorrect reference to Valeant's prior stake in Allergan)

Valeant slashes stake in Allergan after losing bid

- (Refiles Nov. 20 story to correct reference to previous stake)

CORRECTED-Valeant slashes stake in Allergan after losing bid

Nov 20 - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent, three days after Actavis Plc trumped its offer for the Botox maker.

Valeant Pharma says may buy back up to $2 billion worth of securities

- Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it bought back no securities.

Valeant Pharma says may buy back up to $2 bln worth of securities

- Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it bought back no securities.

UPDATE 1-Valeant Pharma says may buy back up to $2 bln worth of securities

Nov 20 - Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it bought back no securities.

Valeant Pharma may buy back up to $2 bln worth of securities

Nov 20 - Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion in senior notes, shares and other securities.

Select another date:
Search Stocks